Press Releases May 21, 2026 05:00 PM

Navient declares second quarter common stock dividend

Navient announces Q2 2026 dividend payment of $0.16 per share

By Marcus Reed NAVI

Navient Corporation declared a second quarter 2026 dividend of $0.16 per common share, payable on June 19, 2026, to shareholders of record as of June 5, 2026. The company continues to focus on responsible lending, refinancing options, and financial services through its Earnest business unit.

Navient declares second quarter common stock dividend
NAVI

Key Points

  • Navient's board approved a $0.16 per share dividend for Q2 2026.
  • Dividend payment date is June 19, 2026, with record date June 5, 2026.
  • Navient operates in education finance, portfolio management, and digital financial services sectors.

HERNDON, Va., May 21, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced that its board of directors approved a 2026 second quarter dividend of $0.16 per share on the company's common stock.

The second quarter 2026 dividend will be paid on June 19, 2026, to shareholders of record at the close of business on June 5, 2026.

About Navient
Navient (Nasdaq: NAVI) creates long-term value for customers and investors with responsible lending, flexible refinancing, trusted servicing oversight, and decades of education finance and portfolio management expertise. Through our Earnest business, we help customers confidently achieve financial success through digital financial services. Our employees thrive in a culture of belonging, where they are supported and proud to deliver meaningful outcomes. Learn more on Navient.com.

Contact:
Media: Cate Fitzgerald, 703-831-6347, [email protected]
Investors: Jen Earyes, 571-592-8582, [email protected]


Risks

  • Future dividend payments depend on company earnings and economic conditions affecting lending and financial services sectors.
  • Potential regulatory changes impacting student loans and financial services could affect company performance.
  • Economic downturns could reduce demand for refinancing and lending products, impacting revenues and dividends.

More from Press Releases

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Jun 4, 2026 TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology Jun 4, 2026 Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets Jun 4, 2026 Satellogic to Participate in June Investor Conferences Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. Jun 4, 2026